臺灣癌症用藥事前審查實作指引
0.2.0 - ci-build
臺灣癌症用藥事前審查實作指引
0.2.0 - ci-build
This page is part of the 臺灣癌症用藥事前審查實作指引(TWPAS IG) (v0.2.0: Releases) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
藥物使用狀態：completed
藥物處方終止原因：Try another treatment first (MedicationRequest Status Reason Codes#altchoice)
意圖：Order ( medicationRequest Intent#order)
自費註記：健保 (NHI-藥物類型#nhi)
藥品代碼：ANTI-CUGH SYRUP 60ML (臺灣健保用藥品項#A000755151)
病人：Patient/pat-min ""
藥品使用頻率及服用時間：1W3D
藥物每次處方劑量(單位)：4 (Tablet (Orderable Drug Form#TAB))
藥物處方起始日期：2024-05-01
藥物處方終止日期：2024-05-07